Neumora stock

Neumora Stock

HealthTech

Looking to sell Neumora stock or options?

Founded: 2019Funding to Date: $612Mhttps://www.neumoratx.com

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company established to tackle the global brain disease crisis through a fundamentally different approach to developing treatments for brain disorders. The company has swiftly expanded its therapeutic pipeline, which now includes seven clinical and preclinical neuroscience programs targeting novel mechanisms for a wide range of underserved neuropsychiatric and neurodegenerative conditions. Neumora plans to advance its pipeline by initiating multiple clinical trials across its programs in the next 12 to 18 months, aiming for numerous anticipated data readouts.

Investors Include:

SoftBank Investment Advisers, Gershon Capital, Amgen, Biomatics Capital, ARCH Venture Partners.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more